In 2010, Richard T. Clark earned $5.97M in total compensation at Merck & Co., including $1.86M salary and $4.06M in stock. Most recently acquired 1,502 shares in Nov 2021. Currently holds stock worth $12.05M. Led Merck & Co. as CEO for 5 years.
Compensation History
Annual executive compensation data for Richard T. Clark, including salary, bonuses, and stock awards.
Year
2010
Total Compensation
$5.97M
Salary
$1.86M
Bonus
$0.00
Other
$54.18K
Salary
$1.86MBoard Justification
Merck's compensation philosophy aims to align executive pay with company performance, focusing on long-term value creation and retention of top talent.
Bonus
$0.00Board Justification
No bonus was awarded for the year 2010 as the focus was on long-term performance metrics.
Other Compensation
$54.18KBoard Justification
Other compensation includes financial counseling, personal use of company aircraft, company car, and security monitoring reimbursement.
Restricted Stock
Board Justification
The number of shares of Merck common stock that vested in 2010 under the 2008-2010 PSU Award Cycle based on performance against EPS goals.
Performance Metrics
The performance metrics for the CEO's compensation in 2010 were primarily based on the achievement of EPS goals and overall company performance as reflected in the Company Scorecard.
Richard T. Clark
Ex-CEO of Merck & Co.
Education
Not specified
Field of Expertise
Healthcare & Life Sciences - Pharmaceuticals
Sector of Economy
Healthcare
Born
October 1, 1946 - 79 years ago
CEO of Merck & Co. for
5 years 7 months (May 2005 - Dec 2010)
Previous Experience
President of Medco Health Solutions
Holdings
Track Richard T. Clark's stock holdings and portfolio value over time.
Insider Trading
Richard T. Clark's recent stock transactions, purchases, and sales filed with the SEC.
1,502 shares
ADP
Nov 10, 2021
Received
1,890 shares
ADP
Nov 11, 2020
Received
1,953 shares
ADP
Nov 12, 2019
Received
2,188 shares
ADP
Nov 6, 2018
Received
2,705 shares
ADP
Nov 7, 2017
Received
3,290 shares
ADP
Nov 8, 2016
Received
3,220 shares
ADP
Nov 10, 2015
Received
4,412.86 shares
ADP
Nov 11, 2014
Received
2,905 shares
ADP
Nov 12, 2013
Received
3,687 shares
ADP
Nov 13, 2012
Received
Rivals
Compare Richard T. Clark with competitor CEOs and industry peers.
Albert Bourla
CEO of Pfizer
2024 Compensation
Stock
$0.00
Salary
$1.80M
Bonus
$7.02M
Other
$996.06K
Total Holdings
$18.14M
Daniel O'Day
CEO of Gilead Sciences
2024 Compensation
Stock
$18.79M
Salary
$1.77M
Bonus
$0.00
Other
$1.34M
Total Holdings
$23.48M
Joseph K. Belanoff, M.D.
Founder and CEO of Corcept Therapeutics
2023 Compensation
Stock
$0.00
Salary
$1.10M
Bonus
$1.32M
Other
$22.50K
Total Holdings
$21.20M
Joaquin Duato
CEO of Johnson & Johnson
2024 Compensation
Stock
$7.13M
Salary
$1.60M
Bonus
$3.22M
Other
$1.08M
Total Holdings
$1.09M
Stéphane Bancel
CEO of Moderna
2023 Compensation
Stock
$0.00
Salary
$1.58M
Bonus
$1.91M
Other
$1.07M
Total Holdings
$335.71M
Christopher Boerner
CEO of Bristol-Myers Squibb
2023 Compensation
Stock
$0.00
Salary
$1.50M
Bonus
$0.00
Other
$311.64K
Total Holdings
$7.39M